Similar Search Results

Intellectual property marketplaces and how they work : evidence from German pharmaceutical firms

Andersen, Birgitte; Rossi, Federica; Stephan, Johannes - In: Intereconomics : review of European economic policy 45 (2010) 1, pp. 35-47

This article examines a sample of German pharmaceutical firms to highlight the strategic reasons why firms participate in various intellectual property (IP) marketplaces, both proprietary (patents and copyrights) and non-proprietary (open source and non-patented technology). The obstacles that...

Persistent link: https://www.econbiz.de/10009659550

Investments in pharmaceuticals before and after trips

Kyle, Margaret K.; McGahan, Anita M. - In: The review of economics and statistics 94 (2012) 4, pp. 1157-1172

Persistent link: https://www.econbiz.de/10009668418

Evergreening, patent challenges, and effective market life in pharmaceuticals

Hemphill, C. Scott; Sampat, Bhaven N. - In: Journal of health economics 31 (2012) 2, pp. 327-339

Persistent link: https://www.econbiz.de/10009625701

Biopharmaceuticals under the patient protection and affordable care act : determining the appropriate market and data exclusive periods

Gitter, Donna M. - In: The changing face of US patent law and its impact on …, (pp. 211-229). 2013

Persistent link: https://www.econbiz.de/10009788426

The new political economy of pharmaceuticals : production, innnovation and TRIPS in the global south

Löfgren, Hans (contributor) - 2013

"Some two decades will shortly have passed since the WTO's Trade Related Aspects of Intellectual Property Rights agreement came into force in 1995. TRIPS is widely considered to have had a negative impact on access to medicines through its rules on pharmaceutical patents. This volume is the...

Persistent link: https://www.econbiz.de/10009793209

Balancing the right to know and the privacy of the patent system : a case study on oncology medicines in Thailand

Yamabhai, Inthira; Smith, Richard - In: International journal of intellectual property … 6 (2013) 4, pp. 272-284

Persistent link: https://www.econbiz.de/10010252982

Incentives for product and process innovations : a case for the Drug industry

Bhan, Aditya; Kabiraj, Tarun - In: Indian economic review : biannual journal of the Delhi … 49 (2014) 2, pp. 193-204

Persistent link: https://www.econbiz.de/10011444193

Obvious to try and non-obviousness post KSR : origins and implications

Dhulap, Sivakami; Joshi, Anshu; Kulkarni, M. G. - In: International journal of intellectual property … 8 (2015) 3/4, pp. 190-206

Persistent link: https://www.econbiz.de/10011549433

The effect of intellectual property rights on domestic innovation in the pharmaceutical sector

Gamba, Simona - 2016

This paper analyses the causal impact of Intellectual Property Rights (IPR) on pharmaceutical innovation in a panel of 74 countries. The identification strategy exploits the different timing across countries of two sets of IPR reforms. Domestic innovation is measured as citation-weighted...

Persistent link: https://www.econbiz.de/10011509446

Die Produktion von Recht : eine selbstreferentielle Theorie der Wirtschaft, angewandt auf den Fall des Arzneimittelpatentrechts

Hutter, Michael - 1989

Persistent link: https://www.econbiz.de/10011519374